Ranibizumab Likely Linked To Better Age-Related Macular Degeneration Outcomes

Ranibizumab has potential to prevent blindness and visual impairment from age-related macular degeneration in non-Hispanic Caucasian patients, according to a computer-modeling study carried out by scientists at the Wilmer Eye Institute, The Johns Hopkins University, Baltimore. They reported their findings in Archives of Ophthalmology...

Full Story →